Focus Areas

Women’s Global Health Imperative

Conducting rigorous epidemiologic, biomedical, socio-behavioral and implementation research to improve infectious disease and chronic health outcomes.

Research conducted by RTI's Women's Global Health Imperative (WGHI) informs the design, implementation and scale-up of new programs, monitoring and evaluation systems, and health policies around the world—particularly as they pertain to addressing health inequities. Our areas of expertise include: 

  • Biomedical prevention strategies
  • Socio-behavioral acceptability and adherence research on novel HIV prevention products
  • Mixed-methods, community-engaged research
  • The intersection of violence, education, and economic opportunities on adolescent health
  • Implementation, scale-up, and improvement of health services delivery
  • Increasing engagement in HIV services among key and hard-to-reach populations
  • The effects of poverty and gender-based violence on women’s health over the lifecycle
Maps highlighting locations in which the Women's Global Health Imperative has collaborated

Women’s Global Health Imperative works with many collaborators in cities around the U.S. and throughout the continent of Africa. These long-held and continuing relationships have greatly enriched their work and research.

The epidemiologists and biomedical and behavioral scientists at WGHI have developed an international reputation as experts in women’s health and global health. WGHI is affiliated with the School of Medicine at the University of California, San Francisco, and the School of Public Health at the University of California, Berkeley, where our investigators serve as faculty members. We also have more than 20 research partners at academic, research and nonprofit organizations in India, Kenya, Malawi, South Africa, Uganda, Zambia, Zimbabwe, the United Kingdom and the United States.

Engage Our Services

We are looking forward to hearing about your project and identifying how our team of experts can help!

Contact Us

Funding Resources

The Women’s Global Health Imperative and its programs are funded by a broad range of sources, including the United States Agency for International Development, the Bill & Melinda Gates Foundation, the Microbicide Trials Network, and the National Institute of Allergy and Infectious Diseases.

The TIP program is developing an implantable HIV prevention device, also known as a Thin-Film Polymer Device Injectable for HIV Prevention (TIP). The TIP Program is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of RTI International and do not necessarily reflect the views of USAID or the United States Government.

Other studies were designed and implemented by the Microbicide Trials Network (MTN)—funded by the National Institute of Allergy and Infectious Diseases through individual grants (UM1AI068633, UM1AI068615 and UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

RTI uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies. If you would like to know more about cookies and how to manage them please view our Privacy Policy. Learn More.

Got it!